MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 11.04.2026
Enlivex Therapeutics Ltd. Kurshistorie 2011-2026 | ENLV
Kurshistorie Jährlich Enlivex Therapeutics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.96 | 0.89 | 1.52 | 2.51 | 6.25 | 8.43 | 8.39 | 6.19 | 18.3 | 41.6 | 155 | 256 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 256 | 0.89 | 42.1 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
BioNTech SE
BNTX
|
91.2 | $ 97.54 | 2.14 % | $ 27.2 B | Germany |
 |
Aligos Therapeutics
ALGS
|
6.67 | $ 8.65 | 8.19 % | $ 85.5 M |  USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.63 | -2.42 % | $ 8.73 B |  Australia |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Esperion Therapeutics
ESPR
|
2.7 | $ 2.14 | -1.38 % | $ 445 M | USA |
 |
Evogene Ltd.
EVGN
|
0.81 | $ 0.81 | -0.07 % | $ 27.9 M |  Israel |
 |
Amphastar Pharmaceuticals
AMPH
|
26.7 | $ 20.47 | 0.49 % | $ 957 M | USA |
 |
Genmab A/S
GMAB
|
33.5 | $ 28.2 | -0.18 % | $ 18 B |  Danmark |
 |
Grifols, S.A.
GRFS
|
6.65 | $ 8.19 | -0.24 % | $ 6.83 B |  Spain |
 |
GT Biopharma
GTBP
|
0.47 | $ 0.36 | -2.82 % | $ 1.98 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Halozyme Therapeutics
HALO
|
80.6 | $ 67.06 | -1.12 % | $ 8.04 B | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Harmony Biosciences Holdings
HRMY
|
28 | $ 28.69 | -0.69 % | $ 1.65 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.3 | $ 1.41 | 0.71 % | $ 363 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 2.96 | 1.37 % | $ 4.87 M | Israel |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Aquestive Therapeutics
AQST
|
4.37 | $ 4.16 | 1.84 % | $ 445 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 24.01 | -0.85 % | $ 3.05 B | USA |
 |
ImmuCell Corporation
ICCC
|
6.43 | $ 7.12 | 1.14 % | $ 64.3 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Celldex Therapeutics
CLDX
|
30.7 | $ 32.24 | - | $ 2.14 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.48 | -0.67 % | $ 394 M | Britain |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
|
Immatics N.V.
IMTX
|
8 | $ 10.48 | 0.43 % | $ 659 M | Germany |
 |
Cidara Therapeutics
CDTX
|
23.4 | - | - | $ 1.41 B | USA |
 |
Incyte Corporation
INCY
|
99.7 | $ 94.86 | -1.26 % | $ 18.5 B | USA |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.61 | 2.35 % | $ 16.4 M | USA |
 |
InflaRx N.V.
IFRX
|
0.94 | $ 1.05 | 4.5 % | $ 152 M | Germany |
 |
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | Britain |
 |
Inventiva S.A.
IVA
|
3.07 | $ 5.18 | -1.52 % | $ 138 M | France |